The relationship between anti-thyroid peroxidase serum levels with prognostic factors in breast cancer and two- year survival of patients

سال انتشار: 1396
محل انتشار: سومین سمپوزیوم بین المللی سرطان نسترن
کد COI اختصاصی: NASTARANCANSER03_067
زبان مقاله: انگلیسی
تعداد مشاهده: 412

نویسندگان

Department Of Clinical Biochemistry ,Faculty Of Medicine,Mashhad University Of Medical Sciences,Mashhad,Iran

چکیده

Anti-Thyroid peroxidase (Anti-TPO) is an autoantibody secreted by the thyroid gland, which is naturally measurable in small quantities in serum. According to the studies carried out, this autoantibody may be used as a marker of prognosis in breast cancer. Of This study the aims was to evaluate the relationship between Anti-TPO serum levels with prognostic factors in breast cancer and two-year survival ofpatients in Qaem hospital Mashhad Iran. To implement this project, 50 patients suffering from breast cancer who referred to Qaem Hospital in Mashhad during the years 2009-2010 were selected.Metastatic patients were excluded from the study and informed consent was obtained from all the patients. The serum levels of Anti-TPO was measured by Elisa Kit (monobind cristal company) Therelationship between the levels of Anti-TPO autoantibody with Estrogen Receptor(ER) , Progesterone Receptor(PR), Human Epidermal Cell Growth Factor Receptor 2 (HER-2), tumor grade and stage wasdetermined in addition to the relationship between these factors with two-year survival. Data was analyzed using SPSS software version 20 and P-value of less than 0.05 was considered significant. Themean serum level of Anti-TPO in patients was equal to 21.58 IU/mL which is within the normal range (less than 40 IU/mL). No significant relationship was found between Anti-TPO serum levels, tumorgrade (p-value=0/474), disease stage (p-value=0/507), ER (p-value=0/1), PR (p-value=1/000), HER-2 (p-value=1/000), two-year disease-free survival (p-value=0/379) and life status (p-value=0/351). Mostpatients were in stage 3a and low patients are in stage 4. Most patients are in grade 2 and least patients were in grade 1. According to the results obtained in this study, Anti-TPO serum levels had nosignificant relationship with any of the prognostic factors in breast cancer and two-year survival of patients including patients with and without the relapse of illness.

کلیدواژه ها

Breast Cancer, Cancer Symptoms, Cancer Diagnosis, Cancer Prevention, Cancer Treatment and Management

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.